nach oben

The Journal of Behavioral Health Services & Research

Erschienen in:

03.11.2023

Commentary on the Revision of SAMHSA’s National Outcome Measures (NOMs) for Discretionary Programs

verfasst von: Michelle Riske-Morris, PhD, JD, David L. Hussey, PhD, LISW-S, Tugba Olgac, PhD, LSW, Jesse Bassett, M.Div., Grayson Holt

Erschienen in: The Journal of Behavioral Health Services & Research | Ausgabe 2/2024

Einloggen, um Zugang zu erhalten

Abstract

Data collection is an integral part of government agencies like the Substance Abuse and Mental Health Administration (SAMHSA), for reporting program outcomes and accountability. SAMHSA-funded community behavioral health programs have been evaluated by the National Outcome Measures (NOMs) since 2007. NOMs collects data on important aspects of client health including but not limited to mental health symptoms, functioning, and social connectedness through interviews with clients. Since its inception, NOMs has gone through a number of revisions. The most recent revision in 2021 has significant implications for program evaluation and research. This commentary provides an overview of the history of the NOMs followed by a review and critique of the recent changes with a particular attention to revisions in how responses are recorded. Implications of the NOMs are discussed with respect to its utility in evaluation, practice, and research.

Substance Abuse and Mental Health Services Administration. Key substance use and mental health indicators in the United States: results from the 2020 National Survey on Drug Use and Health. Center for Behavioral Health Statistics and Quality. Publication Number PEP21-07-01-003, NSDUH Series H-56, October, 2021. Available at https://www.samhsa.gov/data/sites/default/files/reports/rpt35325/NSDUHFFRPDFWHTMLFiles2020/2020NSDUHFFR1PDFW102121.pdf. Accessed 7 February, 2022.

Woodward, A. The CBHSQ report: the substance abuse prevention and treatment block grant is still important even with the expansion of Medicaid. January, 2016. Substance Abuse and Mental Health Services Administration, Center for Behavioral Health Statistics and Quality. Available at https://www.samhsa.gov/data/report/substance-abuse-prevention-and-treatment-block-grant-still-important-even-expansion-medicaid. Accessed 7 February, 2022.

Center for Substance Abuse Treatment and Center for Substance Abuse Prevention. Independent evaluation of the substance abuse prevention and treatment block grant program: final evaluation report. Substance Abuse and Mental Health Services Administration. 2009. Available at https://www.samhsa.gov/sites/default/files/grants/sapt-bg-evaluation-final-report.pdf. Accessed 7 February, 2022.

Darby, K. and Kinnevy, S. GPRA and the development of performance measures. Journal of Evidence-Based Social Work 2010; 7: 5–14. Available at https://www.tandfonline.com/doi/full/https://doi.org/10.1080/15433710903175833. Accessed 2 August, 2023.

Radin, B. A. Intergovernmental relationships and the federal performance movement. The Journal of Federalism 2010; 30: 143–158. Available at https://academic.oup.com/publius/article/30/1/143/1900617. Accessed 2 August, 2023.

Substance Abuse and Mental Health Services Administration. Government Performance Results Act (GPRA). Available at https://www.samhsa.gov/sites/default/files/gpra-fact-sheet.pdf. Accessed 2 August 2023.

Substance Abuse and Mental Health Services Administration. Orientation manual. Center for substance abuse prevention. May, 2009. Available at https://nasadad.org/wp-content/uploads/2011/10/SAMHSA-CSAP-Orientation.pdf. Accessed 9 February, 2023.

Substance Abuse and Mental Health Services Administration. Center for Mental Health Services (CMHS) National Outcome Measures (NOMs) Client-Level Measures for programs providing direct services (services activities): frequently asked questions. 2021. Available at https://spars.samhsa.gov/sites/default/files/2022-02/CMHS%20Services%20Frequently%20Asked%20Questions%20%28FAQs%29.pdf Accessed 4 October, 2023.

Substance Abuse and Mental Health Services Administration. CMHS NOMS supporting statement. OMB Control No: 0930–0285. OMB Forms. 2006. Available at https://omb.report/icr/200701-0930-001. Accessed 3 August, 2023.

10.

Task Force on a Mental Health Consumer Oriented Report Card. The MHSIP consumer-oriented report card. Center for Mental Health Services. 1996.

11.

Brunk M. Children’s indicator workgroup report. Sixteen state indicator project. Mental Health Statistics Improvement Program. 2001.

12.

WHO ASSIST Working Group. The alcohol, smoking and substance involvement screening test (ASSIST): development, reliability and feasibility. Addiction 2002; 97(9):1183–1194. Available at https://onlinelibrary.wiley.com/doi/full/https://doi.org/10.1046/j.1360-0443.2002.00185.x. Accessed 7 February, 2023.

13.

Kessler RC, Andrews G, Colpe LJ, et al. Short screening scales to monitor population prevalences and trends in nonspecific psychological distress. Psychological Medicine 2002. 32(6): 959–976. Available at https://doi.org/10.1017/s0033291702006074. Accessed 7 February, 2023.

14.

Power M. Chapter 10, Development of a common instrument for quality of life. In: A. Nosikov, C. Gudex (Eds.). Developing common instruments for health surveys. Amsterdam, The Netherlands: IOS Press, 2003, pp. 145–163 Available at https://www.euro.who.int/__data/assets/pdf_file/0015/101193/WA9502003EU.pdf. Accessed 7 February, 2023.

15.

Kessler RC, Barker PR, Colpe LJ, et al. Screening for serious mental illness in the general population. Archives of General Psychiatry 2003; 60(2):184–189. Available at https://pubmed.ncbi.nlm.nih.gov/12578436/. Accessed 7 February, 2023.

16.

Furukawa TA, Kessler RC, Slade T, et al. The performance of the K6 and K10 screening scales for psychological distress in the Australian National Survey of Mental Health and Well-Being. Psychological Medicine 2003; 33(2):357–362. Available at https://doi.org/10.1017/s0033291702006700. Accessed 7 February, 2023.

17.

Green JG, Gruber MJ, Sampson, NA, et al. Improving the K6 short scale to predict serious emotional disturbance in adolescents in the USA. International Journal of Methods in Psychiatric Research 2010; 19(S1): 23–35. Available at https://doi.org/10.1002/mpr.314. Accessed 7 February, 2023.

18.

Schmidt S, Mühlan H, & Power M. The EUROHIS-QOL 8-item index: psychometric results of a cross-cultural field study. European Journal of Public Health 2006; 16(4): 420–428. Available at https://doi.org/10.1093/eurpub/cki155. Accessed 7 February, 2023.

19.

Graham, C. Agency information collection activities: proposed collection; comment request. Federal Register 2021; 86(145). Available at https://www.govinfo.gov/content/pkg/FR-2021-08-02/pdf/2021-16407.pdf. Accessed 7 February, 2023.

20.

Uniform reporting summary output tables executive summary. Washington, DC: Substance Abuse and Mental Health Services Administration, 2022. Available at https://www.samhsa.gov/data/report/2021-uniform-reporting-system-urs-output-tables.

21.

Substance Abuse and Mental Health Services Administration. NOMS table of changes. OMB Control No: 0930–0285. OMB Forms. 2021. Available at https://omb.report/icr/202203-0930-002/doc/119334001. Accessed 4 October, 2023.

22.

DeVellis, R., F. Scale development theory and applications. Third Edition. Sage Publication, 2011.

23.

Substance Abuse and Mental Health Services Administration. GPRA public comments response matrix. OMB Control No: 0930–0285. OMB Forms. 2021. Available at https://omb.report/icr/202203-0930-002/doc/119333901. Accessed 3 August, 2023.

24.

Wilks, S. E., Heintz, M. E., Lemieux, C. M., & Du, X. Assessing social connectedness among persons with schizophrenia: psychometric evaluation of the perceived social connectedness scale. The Journal of Behavioral Health Services & Research 2020; 47: 113–125. Available at https://link.springer.com/article/https://doi.org/10.1007/s11414-019-09656-6. Accessed 3 August, 2023.

Titel: Commentary on the Revision of SAMHSA’s National Outcome Measures (NOMs) for Discretionary Programs
verfasst von: Michelle Riske-Morris, PhD, JD
David L. Hussey, PhD, LISW-S
Tugba Olgac, PhD, LSW
Jesse Bassett, M.Div.
Grayson Holt
Publikationsdatum: 03.11.2023
Verlag: Springer US
Erschienen in: The Journal of Behavioral Health Services & Research / Ausgabe 2/2024
Print ISSN: 1094-3412
Elektronische ISSN: 1556-3308
DOI: https://doi.org/10.1007/s11414-023-09868-x

Multidimensional Family Therapy for Justice-Involved Young Adults with Substance Use Disorders

Open Access

From Scientific Research to Practical Implementations: Applications to Improve Data Quality in Child Welfare

Patterns and Predictors of Sustained Training and Technical Assistance Engagement Among Addiction Treatment and Affiliated Providers

Exploring the Impact of External Facilitation Using Evidence-Based Implementation Strategies for Increasing Motivational Interviewing Capacity Among Outpatient Substance Use Disorder (SUD) Treatment Providers

Native Hawaiians’ Views on Depression and Preferred Behavioral Health Treatments: a Preliminary Qualitative Investigation

Mental Health Impact of COVID Pandemic on Veterans Transitioning from Military

Open Access

Neu im Fachgebiet Psychiatrie

Digitale Therapie lindert Borderline-Persönlichkeitsstörung

23.04.2025
Borderline-Muster
Nachrichten

Eine rein digitale Therapie ohne therapeutische Unterstützung kann die Symptomatik bei Borderline-Persönlichkeitsstörung bereits etwas lindern, auch scheint sie das Suizidrisiko zu mindern. Darauf deuten Ergebnisse einer großen kontrollierten Studie. Die Effekte sind aber eher gering.

Schadet Schichtarbeit dem Gehirn?

17.04.2025
AAN-Jahrestagung 2025
Kongressbericht

Eine große Registerstudie bestätigt, dass Schichtarbeit mit einem erhöhten Risiko für psychische und neurologische Erkrankungen einhergeht, sowie mit einer Volumenabnahme in Gehirnarealen, die für Depression, Angst und kognitive Funktionen relevant sind.

Starke Menopausensymptome: ein Hinweis auf kognitive Veränderungen?

17.04.2025
Perimenopause
Nachrichten

Stärkere Beschwerden in der Perimenopause sind mit einer reduzierten kognitiven Funktion in den mittleren und späteren Lebensjahren assoziiert. Auch das Verhalten kann sich ändern, wie eine Studie zeigt. Beides steht womöglich für erhöhte Demenzgefährdung.

Was tun, wenn pneumologische Medikamente Psyche und Blutbild verändern?

17.04.2025
DGP 2025
Kongressbericht

Arzneimittel für Patienten mit Mukoviszidose oder pulmonaler arterieller Hypertonie wirken offenbar nicht nur auf die Lunge. Was es in der Praxis zu beachten gilt, wurde beim Pneumologie-Kongress erläutert.

Update Psychiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Commentary on the Revision of SAMHSA’s National Outcome Measures (NOMs) for Discretionary Programs

Abstract

Weitere Artikel der Ausgabe 2/2024

Multidimensional Family Therapy for Justice-Involved Young Adults with Substance Use Disorders

From Scientific Research to Practical Implementations: Applications to Improve Data Quality in Child Welfare

Patterns and Predictors of Sustained Training and Technical Assistance Engagement Among Addiction Treatment and Affiliated Providers

Exploring the Impact of External Facilitation Using Evidence-Based Implementation Strategies for Increasing Motivational Interviewing Capacity Among Outpatient Substance Use Disorder (SUD) Treatment Providers

Native Hawaiians’ Views on Depression and Preferred Behavioral Health Treatments: a Preliminary Qualitative Investigation

Mental Health Impact of COVID Pandemic on Veterans Transitioning from Military

Neu im Fachgebiet Psychiatrie

Digitale Therapie lindert Borderline-Persönlichkeitsstörung

Schadet Schichtarbeit dem Gehirn?

Starke Menopausensymptome: ein Hinweis auf kognitive Veränderungen?

Was tun, wenn pneumologische Medikamente Psyche und Blutbild verändern?

Update Psychiatrie

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten